Related Experiment Video
Updated: Jan 11, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Advancing Obstructive Sleep Apnea Management: Recent Trends from Conventional to Innovative Therapies.
1Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, College of Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.
Obstructive sleep apnea (OSA) treatment is evolving beyond positive airway pressure (PAP). New precision medicine approaches, including hypoglossal nerve stimulation and pharmacotherapy, offer tailored solutions for improved patient outcomes.
Area of Science:
- Sleep Medicine
- Respiratory Medicine
- Cardiology
Background:
- Obstructive sleep apnea (OSA) is a prevalent condition causing airway collapse during sleep, leading to hypoxemia and sleep fragmentation.
- Untreated OSA significantly increases risks for cardiovascular, metabolic, and neurocognitive issues, imposing a substantial socioeconomic burden.
- Positive airway pressure (PAP) is the standard treatment, but poor long-term adherence necessitates exploring alternative patient-centered strategies.
Purpose of the Study:
- To review current evidence on conventional and emerging therapies for obstructive sleep apnea.
- To highlight the shift towards precision medicine and phenotype-driven management in OSA.
- To discuss innovative strategies aimed at improving treatment adherence and patient quality of life.
Main Methods:
- Systematic review of existing literature on OSA treatments.
- Analysis of clinical trial data for conventional and novel therapeutic modalities.
- Synthesis of evidence on the efficacy and tolerability of various OSA interventions.
Main Results:
- Conventional OSA therapies (oral appliances, surgery, weight reduction, positional therapy) offer benefits but show variable efficacy and tolerability.
- Emerging strategies like hypoglossal nerve stimulation (HGNS) and glucagon-like peptide-1 receptor agonists represent precision medicine tailored to OSA phenotypes.
- These innovative approaches aim to address limitations of current treatments and improve patient adherence.
Conclusions:
- The management of OSA is transitioning from a one-size-fits-all approach to integrated, phenotype-driven care.
- Precision medicine offers promising avenues for personalized OSA treatment, enhancing effectiveness and patient experience.
- Further research and clinical implementation of novel therapies are crucial for optimizing OSA management and improving long-term health outcomes.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Cardiopulmonary Resuscitation II: ACLS Airway Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

